ClinicalTrials.Veeva

Menu

Child Development and Genetic Biomarkers

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Unknown

Conditions

Child Development

Study type

Observational

Funder types

Other

Identifiers

NCT04660942
202001521A3

Details and patient eligibility

About

A study of the relation between genetic biomarkers and child development in Taiwan.

Full description

The interaction between gene and environment (G×E) can be a very complicated process that influences child development. As a pilot study of child development biomarkers, this study investigates genes related to child development.

Enrollment

446 estimated patients

Sex

All

Ages

1 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria of Healthy Child:

  • Age 2-18 y/o
  • Agree to sign informed consent

Exclusion Criteria of Healthy Child:

  • Central nervous system disease
  • Neuromuscular Disorders
  • Congenital Abnormality
  • Genetic Disease
  • Dysesthesia
  • Hearing Impairment

Inclusion Criteria of Child with developmental delay:

  • Patients with Language Disorder
  • Age 2-18 y/o
  • Agree to sign informed consent

Exclusion Criteria of Child with developmental delay:

  • Hearing Impairment

Inclusion Criteria of Adult:

  • His or her child participated in this study, and gene abnormality was found.

Trial design

446 participants in 2 patient groups

Control
Description:
Healthy child
Experimental
Description:
Patients with developmental delay

Trial contacts and locations

1

Loading...

Central trial contact

Chia-Ling Chen, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems